Rapid
identification and antimicrobial susceptibility testing of the causative
agent(s) of bloodstream infections may impact on the clinical outcome of patients,
which is directly
related to the prompt administration of an effective antimicrobial therapy.
Empirical
antimicrobial therapy is chosen on the basis of clinical and epidemiological
data and it is administered immediately after blood sampling but, in a significant
number of cases, it has to be streamlined on the basis of the microbiological
report.
Rapid
identification has a clinically relevant impact on the timely selection of an
appropriate antimicrobial therapy, especially in low-prevalence areas for antimicrobial
resistance.
No comments:
Post a Comment